Central Drugs Standard Control Organisation (CDSCO) for the use of its Oxiris blood purification filter for the treatment of COVID-19 patients.The filter is intended to be used in the critically ill COVID-19 patients in need of blood purification where excessive inflammatory mediators are present, Baxter India said in a statement."The COVID-19 cases in India have been spiralling and putting pressure on our the healthcare system.
This approval has come at a crucial time when such filter sets are much required to ease the burden on healthcare providers," Baxter India General Manager Ravinder Dang said.The company hopes that the availability of Oxiris will go a long way in fighting the COVID-19 cases in India, he added.During blood.